The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes

Kim Ho-Sook; Lim Younghae; Oh Minkyung; Ghim Jong-lyul; Kim Eun-Young; Kim Dong-Hyun; Shin Jae-Gook

首页> 外文期刊>British Journal of Clinical Pharmacology >The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes

【24h】

The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes

机译：氯吡格雷和西洛他唑与CYP2C19和CYP3A5基因型的药代动力学和药效相互作用

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

AimThe primary objective of the present study was to evaluate the pharmacokinetic and pharmacodynamic interactions between clopidogrel and cilostazol in relation to the CYP2C19 and CYP3A5 genotypes.

机译：目的本研究的主要目的是评估氯吡格雷与西洛他唑之间与CYP2C19和CYP3A5基因型相关的药代动力学和药效动力学相互作用。

著录项

来源
《British Journal of Clinical Pharmacology》 |2016年第2期|共12页
作者
Kim Ho-Sook; Lim Younghae; Oh Minkyung; Ghim Jong-lyul; Kim Eun-Young; Kim Dong-Hyun; Shin Jae-Gook;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
cilostazol; clopidogrel; CYP2C19; CYP3A5; drug-drug interaction; pharmacogenomics;

机译：西洛他唑;氯吡格雷;CYP2C19;CYP3A5;药物相互作用;药物基因组学;
入库时间 2022-08-18 09:14:22

相似文献

外文文献
中文文献
专利

1. The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes [J] . Kim Ho-Sook, Lim Younghae, Oh Minkyung, British Journal of Clinical Pharmacology . 2016,第2期

机译：氯吡格雷和西洛他唑与CYP2C19和CYP3A5基因型的药代动力学和药效相互作用
2. CYP2C19 CYP2C19 or CYP3A5 CYP3A5 Genotyping Does Not Predict Clinical Response to Clopidogrel [J] . Rodríguez‐González Fayna, Martínez‐Quintana Efren, Saavedra Pedro, The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2018,第10期

机译：CYP2C19 CYP2C19或CYP3A5 CYP3A5基因分型不能预测对氯吡格雷的临床反应
3. Pharmacokinetics of the new proton pump inhibitor ilaprazole in Chinese healthy subjects in relation to CYP3A5 and CYP2C19 genotypes. [J] . Li Y, Zhang W, Guo D, Clinica chimica acta: International journal of clinical chemistry and applied molecular biology . 2008,第1a2期

机译：新型质子泵抑制剂ilaprazole在中国健康受试者中与CYP3A5和CYP2C19基因型相关的药代动力学。
4. Pharmacokinetic and pharmacodynamic interactions in anesthesia [C] . Vuyk J. World Congress of Total Intravenous Anaesthesia . 2009

机译：麻醉中的药代动力学和药效学相互作用
5. Herb-drug Interactions between Scutellariae Radix and Non-steroidal Anti-inflammatory Drugs: Pharmacokinetic and Pharmacodynamic Impact. [D] . Fong, Yui Kau. 2014

机译：黄cut与非甾体抗炎药之间的药草相互作用：药代动力学和药效学影响。
6. The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes [O] . Ho‐Sook Kim, Younghae Lim, Minkyung Oh, 2016

机译：氯吡格雷和西洛他唑与CYP2C19和CYP3A5基因型的药代动力学和药效相互作用
7. TCT-735 Pharmacodynamic Effect of Adjunctive Cilostazol vs. High-dos Clopidogrel in Acute Coronary Syndrome Patients According to the CYP2C19 Genotype (ACCEL-GENOTYPE) study [O] . Jeong Young-Hoon, Park Yongwhi, Koh Jin-Sin, 2012

机译：根据CYP2C19基因型（ACCEL-GENOTYPE）研究，西洛他唑与高剂量氯吡格雷联合治疗对急性冠脉综合征患者的药效学作用

The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes

摘要

著录项

相似文献

相关主题

期刊订阅